SNBIOSCIENCE
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
SN Bioscience Receives FDA Fast Track Designation for Small Cell Lung Cancer 2024-05-10 12:00
SN BioScience received US FDA Orphan Drug Designation for its Nano Anti-Cancer Drug 'SNB-101' on Pancreatic Cancer 2024-02-29 18:09
SN Bioscience Announces Phase 1 Study Results of SNB-101 (SN-38 Nanoparticle Anti-cancer Drug) at ESMO 2023-10-27 13:34
US FDA Grants Orphan Drug Designation of SN Bioscience's Nano Anti-Cancer Drug 'SNB-101' for Small Cell Lung Cancer 2023-07-21 08:15
SN BioScience and Boryung Announce the Licensing Agreement on Generic Version of Abraxane 2023-01-26 14:31
1